⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Complement Inhibitors Market Outlook Remains Strong During the Forecast Period (2026–2036) with Increasing Adoption of C5 and C3 Targeted Drugs | DelveInsight
globenewswire.com
AZN
IONS
ARWR
REGN
SNY
OMER
SKF commits to a sovereign AI future through strategic partnership with Sferical AI USA - English USA - English
prnewswire.com
ERIC
AZN
Pinetree Therapeutics Announces Exercise of Option to License EGFR Degrader Program by AstraZeneca
prnewswire.com
AZN
IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight
globenewswire.com
NVS
VRTX
BIIB
VTRS
AZN
IONS
TAK
ARWR
WLDN
Alcoholism Treatment Market Report 2026: Revenue to Reach $36.85 Billion in 2026, Growing by $2.27 Billion YoY
globenewswire.com
ADIL
ALKS
AZN
BCO
CATX
LLY
GSK
MRK
PFE
SNY
TEVA
AstraZeneca results: Q1 2026
businesswire.com
AZN
Vanguard Renewables Celebrates Milestone Completion of Three Renewable Natural Gas Projects Alongside Partners
prnewswire.com
TTE
AZN
BLK
FDA Announces Major Steps to Implement Real-Time Clinical Trials
globenewswire.com
AZN
AMGN
Paradigm Health Announces Collaboration with the FDA to Transform Regulatory Review of Clinical Trial Data
prnewswire.com
AMGN
AZN
Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape
globenewswire.com
UCB
AZN
LLY
PFE
ABBV
REGN
AMGN
BMY
SNY
JNJ
TLRY